Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398177 · ClinicalTrials.gov registry record
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A clinical trial of Lymphoma, Non-Hodgkin and Hodgkin's Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- 1
- Study location
NCT00398177 is a study of Lymphoma, Non-Hodgkin and Hodgkin's Disease that is actively recruiting participants, run by Stanford University. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state.
The verdict
NCT00398177, a study of Lymphoma, Non-Hodgkin and Hodgkin's Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 1999-01 |
| Est. Completion | 2099-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398177
The ClinicalTrials.gov registry entry for NCT00398177 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lymphoma, Non-Hodgkin appearing as the primary indexed condition, and to 0 interventions.
NCT00398177 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00398177 about?
NCT00398177 is a clinical study titled "Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease". The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
What is the current status of trial NCT00398177?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 1999-01. Estimated completion is 2099-01.
What conditions does trial NCT00398177 study?
This clinical trial studies the following conditions: Lymphoma, Non-Hodgkin, Hodgkin's Disease.
Who is sponsoring clinical trial NCT00398177?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00398177 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma, Non-Hodgkin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
RECRUITING · Phase 1
-
Family Study of Lymphoproliferative Disorders
RECRUITING
-
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
RECRUITING · Phase 1
-
Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.